| Back |
|
| Show the right door to infections |
| Product Name: |
| Injection |
| Amikacin 100/250/500 mg per 2 ml |
| Fights to kill the infectious organisms |
| Drug of choice for the empirical treatment of sepsis in neonates against Kanamycin and Gentamycin-resistant Gram negative bacteria |
| Amikacin penetrates the blood brain barrier substantially in children with bacterial meningitis and achieves high concentrations. |
| Plays an important role in the management of infections caused by Pseudomonas aeruginosa, the commonest cause of death in patients with extensive burns. |
|
|
| URINARY TRACT INFECTIONS
|
| RESPIRATORY TRACT INFECTIONS
|
| NEONATAL INFECTIONS
|
| MENINGITIS
|
| INFECTIONS IN NEUTROPENIC PATIENTS
|
|
Medical Jr.
| Antimicrobial Agents & Chemotherapy, Jan. 1995, p. 253-255
|
|
| |
|
 |